Brad Kahl, MD, Hematology, Saint Louis, MO, Barnes-Jewish Hospital

BradStevenKahlMD

Hematology Saint Louis, MO

Hematologic Oncology

Professor of Medicine

Dr. Kahl is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kahl's full profile

Already have an account?

Education & Training

  • University of Wisconsin
    University of WisconsinFELLOWSHIP
  • University of Wisconsin
    University of WisconsinRESIDENCY
  • Tufts University School of Medicine
    Tufts University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2023
  • MO State Medical License
    MO State Medical License 2015 - 2021
  • WI State Medical License
    WI State Medical License 1995 - 2015
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
    Brad S. Kahl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
    Brad S. Kahl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Efficacy and Safety of Zanubrutinib in Patients with Treatment-Naive Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with Del(17p): Initial Resu...
    Brad S. Kahl, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Addressing Current Questions and Controversies in the Management of Lymphomas and Chronic Lymphocytic Leukemia (Part 1 of a 2-Part Series) 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • The Prognostic Impact of Baseline Positron Emission Tomography (PET) Imaging in Untreated High Risk (HR) Follicular Lymphoma (FL): Analysis from E0, the Bortezomib Ind... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Five-Year Outcomes of SWOG S0: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Ma... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • ADC Therapeutics Announces Publication of ADCT-402 Data in Clinical Cancer Research
    ADC Therapeutics Announces Publication of ADCT-402 Data in Clinical Cancer ResearchNovember 06, 2019
  • Antibody-Drug Conjugate Shows Early Promise in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Antibody-Drug Conjugate Shows Early Promise in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaNovember 04, 2019
  • OncLive® to Host State of the Science Summit™ on Treatment of Hematologic Malignancies
    OncLive® to Host State of the Science Summit™ on Treatment of Hematologic MalignanciesNovember 05, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations